In July, the FDA approved a new blood test for colorectal cancer screenings that was able to detect 83% of Stage 1, 2 or 3 colorectal cancers in studies.
In July, the FDA approved a new blood test for colorectal cancer screenings that was able to detect 83% of Stage 1, 2 or 3 colorectal cancers in studies.